Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Rebecca Deya, MSN, RN
Research Manager
Baptist MD Anderson Clinical Trials
904.202.7468
rebecca.deya@bmcjax.com
Clinical Trial ID: NCT05384587
A Phase II multicenter, open-label, single-arm dose escalation study of Asciminib monotherapy in 2nd and 1st Line Chronic Phase - Chronic Myelogenous Leukemia "(ASC2ESCALATE)"to reflect the inclusion of a 1L cohort in the study design.
Status
Open
Conditions
Other
Phases
II
Age Group
Adult
Main Investiagtor
Norkin, Maxim
Practice
Bone Marrow
Scope
National
Nct ID Number
NCT05384587
Secondary Trial ID Number
CABL001AUS08
Keywords
Treatment